x
Send Your Inquiry Today
Quick Quote
Angelica sinensis Supplement Manufacturer

Dong Quai Supplement Manufacturer

  • OEM & Private Label Available
  • MOQ from 3,000 finished units
  • Sample 7–15 days after spec confirmation
  • Mass production 4–6 weeks after sample approval
  • cGMP/ISO/HACCP/FSSC

Dong Quai Supplement OEM/ODM Solutions

KS Nutripharma is a Dong Quai supplement manufacturer for OEM, ODM, and private-label programs. We take Angelica sinensis (Chinese angelica, danggui) root from a locked grade through finished women’s wellness capsules, tablets, or powders — with batch COA release.

Dong Quai extract is not a complete material specification. The species, plant part, extract type, marker, and assay method have to be defined before quotes can be compared on a like-for-like basis. We build finished SKUs around Angelica sinensis root powder, ratio extracts, or marker-specified grades for ligustilide, ferulic acid, or polysaccharides, then quote the finished product against the approved specification.

Already have a formula? Send Your BOM

Still deciding the specification? Get a Dong Quai Spec Recommendation

Comparing suppliers? Send Your COA for Comparison

What you confirm so the first quote is usable

Typical project answer

BotanicalDong Quai = Angelica sinensis (Oliv.) Diels = Chinese angelica / danggui. Dried root. Other Angelica species are quoted as different materials
Working gradesRoot powder (identity). Ratio 4:1, 10:1, or 20:1. Ligustilide 1% or 2% HPLC. Ferulic acid 0.1%–1% HPLC (0.3% commonly quoted). Polysaccharide 10%, 20%, or 30% UV when an aqueous grade is required. Final specification is project-dependent
Assay / releaseLigustilide and/or ferulic acid by HPLC; polysaccharide by UV (or the named method on the file). Incoming identity, moisture, microbiology, heavy metals, pesticides, residual solvents as scoped. Sample and commercial batch released against the same spec
Serving math500 mg of a 1% ligustilide extract = 5 mg ligustilide — not 500 mg ligustilide. Illustration only; not a dosage recommendation
Formula architecturesF01 extract · F02 root powder · F03 chasteberry · F04 black cohosh · F05 B6 + magnesium · F06 evening primrose oil · F07 red clover
Recommended formatCapsules first. Tablets when minerals or vitamins drive fill. Softgel or dual SKU when an oil-based ingredient is on the panel. Powder, gummies, and liquids as their own SKUs
Target marketCountry, food-supplement vs herbal-medicine classification, and label and claims review
DocumentsBatch COA · specification sheet · SDS · Halal / Kosher when required · third-party testing (SGS / Eurofins) as scoped
MOQ / lead timeIndicative by format — confirmed after formula, pack, and testing
ProgramOEM / ODM / private-label finished SKUs. Bulk root powder or extract can be quoted on the same project

 

cGMP | ISO 9001 | ISO 22000 | HACCP | FSSC 22000 | Halal | Kosher | In-house lab + third-party pathways (SGS / Eurofins) | Batch COA | Traceable release

-> About Us | Manufacturing Capacity | Certifications | Quality Control

What you receive with a Dong Quai OEM project

  • Matched Angelica sinensis root specification
  • Formula and dosage-form feasibility review
  • Sample based on the approved specification
  • Prototype COA
  • Production quotation by SKU
  • Batch release documentation
  • Packaging and export support

This page is manufacturing feasibility and documentation support — not legal approval of the finished label.

Read More

Dong Quai Supplement Formulation for Private Label SKUs

These are starting architectures for dietary-supplement SKUs — not frozen catalog products and not traditional multi-herb prescriptions. Serving size, extract grade, format, and pack stay customizable.

Choose the closest card, or send a BOM. KS Nutripharma’s formulation team and R&D center match it to your channel and destination market, then lock the A. sinensis root grade against that BOM. You receive a SKU-level cost, feasibility read, and sample plan. Final claim language stays with your brand and local counsel.

Custom nutrient combinations (short B-vitamin lists, iron, folate / 5-MTHF) and other custom stacks (peony, maca, ginger, soy isoflavones, extra GLA oils, or a three-botanical panel) are quoted as custom BOMs after you name the channel and market. Each companion keeps its own specification and claim file. Folate / 5-MTHF in a women’s nutrition BOM does not convert the SKU into a prenatal vitamin.

Already have a formula? Send Your BOM

F01 — Single-Ingredient Dong Quai Extract

For women’s wellness lines that need a concentrated, single-ingredient SKU and a simple Supplement Facts panel. Capsules are the usual start; tablets when the channel wants a compact unit.

Specification: Lock A. sinensis root, extract type, and — if the label will name a marker — ligustilide or ferulic acid with the HPLC method. Fill weight is calculated from extract strength.

F02 — Dong Quai Root Powder

For labels that should show dried root rather than a concentrated extract. Capsules are typical; a two-capsule serving is common when fill exceeds one shell.

Specification: Lock A. sinensis root, particle size, and capsule count versus serving weight. Identity-led SKUs use this card; a numbered marker milligram belongs on F01.

F03 — Dong Quai + Chasteberry (Vitex)

Two-botanical women’s SKUs already sold in natural retail, pairing Dong Quai with Vitex rather than black cohosh or red clover. Capsules first; tablets after compression review.

Specification: Lock both species, both markers and methods, and destination-market warnings. Each botanical keeps its own identity file.

Related manufacturing path: Chasteberry Supplement Manufacturer

F04 — Dong Quai + Black Cohosh

Midlife botanical sets next to menopause supplement assortments, with black cohosh as a separately specified root. Capsules; tablets when the channel wants a compact pair.

Specification: Lock black cohosh identity and triterpene method as a separate spec, plus the Dong Quai marker if named. Claim language follows destination-market requirements.

F05 — Dong Quai + Vitamin B6 + Magnesium

A women’s nutrition formula for brands building a hormone-balance product line, combining Dong Quai with vitamin B6 and magnesium. Tablets often win once the mineral is added; capsules when the salt keeps fill modest.

Specification: Lock B6 form, magnesium salt (oxide versus glycinate changes tablet size), and extract grade. Serving numbers follow destination-market requirements.

F06 — Dong Quai + Evening Primrose Oil

For women’s formulas that already include an oil-based ingredient such as evening primrose oil. Dual SKU (extract capsule + EPO softgel) is the usual path; a single oil-filled softgel after fill-system review.

Specification: Lock EPO identity and GLA specification, plus shell type or dual-SKU pack logic.

Softgel Solutions

F07 — Dong Quai + Red Clover

A phytoestrogen-adjacent botanical pair for brands that already specify a red clover HPLC isoflavone grade — distinct from Vitex (F03) and black cohosh (F04). Capsules.

Specification: Lock red clover isoflavone % and HPLC method as a separate spec.

Related manufacturing path: Red Clover Supplements Manufacturer

Choose the Right Dong Quai Dosage Form: Capsules, Tablets or Powder

Once the formula architecture and target serving are defined, dosage form becomes a manufacturing and commercial decision. The same Dong Quai formula is not automatically transferable across formats. Each path is re-engineered around fill weight, processing conditions, sensory profile, stability, and finished-product assay.

For capsules and tablets, the usual starting material is a dry Dong Quai extract. Oil-based grades are handled as a separate formulation route.

Capsules — when the serving fits a two-piece shell

When to choose it: Quantified-marker formulas, multi-botanical blends, and most single- or dual-active configurations (see F01–F04 and F07).
What changes: Capsules can reduce direct sensory exposure compared with powders. Fill weight and bulk density determine capsule size; gelatin or HPMC shells avoid compression heat.
What must be locked: Fill weight, shell type, and whether one capsule can carry the serving.
Best fit: The usual Dong Quai capsules manufacturer starting path when the target serving fits the selected size and pack.
Hard Capsules

Tablets — when fill exceeds a practical capsule

When to choose it: Higher-load formulas, compact serving formats, or formulas that exceed practical capsule fill limits.
What changes: Higher pack density and, at volume, a lower unit cost. Direct compression is evaluated first; film coating can be scoped for swallowability, moisture, and residual odor. A capsule BOM is re-engineered for compression before a tablet sample.
What must be locked: Blend uniformity, hardness, and compression at sample — before a tablet MOQ is meaningful.
Best fit: The Dong Quai tablets manufacturer path for nutrition stacks and other high-fill BOMs (including F05 and custom nutrient combinations).
Tablets

Powder / stick — a different SKU, not a cheaper capsule

When to choose it: Custom herbal drink mixes — a different selling SKU, not a cheaper F01.
What changes: Serving weight becomes flexible, but the consumer opens the pack every use. Taste, odor, color, dispersion, and moisture-barrier film enter the BOM.
What must be locked: Serving weight, film/barrier pack, and a sensory plan. Specify powder as its own SKU from the start.
Best fit: Convenience formats where the drink-mix serving cannot sit in a practical capsule count.
Powders & Granules

Softgel — when an oil-based ingredient is on the panel

When to choose it: Formulas that already include an oil-based ingredient such as evening primrose oil (F06).
What changes: The oil belongs in a softgel fill. Dry Dong Quai extract is evaluated as a suspension, or the program splits into two finished SKUs.
What must be locked: Fill system, GLA/oil specification, shell type, or dual-SKU pack.
Best fit: Oil-plus-botanical panels. Dry-extract capsules stay on a capsule or tablet path.

Gummies — project-scoped

Feasibility covers piece load, heat, water activity, sensory profile, and finished-product assay. Active-per-piece and serving configuration are confirmed before artwork.

Liquids — feasibility only

A separate review of solvent system, serving volume, preservation, taste, precipitation, light/oxygen exposure, and assay in the finished matrix.

Market & Label Considerations for Dong Quai Supplements

After you pick the SKU architecture, confirm classification and claim language before you freeze the root grade. The same Angelica sinensis root can sit on a dietary-supplement label in one market and on a herbal or traditional-medicine file in another.

Market

Regulatory routeWhat to confirm before formula freeze
United StatesDietary supplement framework (DSHEA)Women’s wellness positioning should remain within the applicable structure/function framework. Disease, fertility-treatment, anemia, or blood-building claims require separate regulatory review. Dong Quai is not an FDA-approved drug
European Union / United KingdomCountry-specific food-supplement and/or herbal-medicine filesSpecies wording and traditional-use language are file-specific. UK files are reviewed separately from EU files
Australia / CanadaComplementary medicine / natural health product paths as applicableProduct-specific indications, listing, or licensing
Other marketsReview requiredLocal classification, claims, notification or registration, and labeling

If the RFQ named

Commercial framing (verify locally)What usually delays artwork
F01–F02Women’s botanical / traditional Angelica sinensis root identityTreat, cure, amenorrhea, anemia, or “blood tonic” disease copy
F03 / F07Multi-botanical women’s wellnessHormone-drug or estrogen-therapy copy
F04Midlife botanical setHot-flash treatment
F05 / custom nutrient stacksNutrition stackPrenatal claims without a prenatal file
F06Oil + botanical dual SKU or softgelCopying a dry-extract claim onto an oil-filled softgel

Pregnancy, medication-use, and other safety cautions should be reviewed as part of the market-specific regulatory file before sampling. We manufacture to the agreed specification and support Supplement Facts / local information-panel layout. Brand owners confirm finished-label compliance with local counsel.

Which Dong Quai Extract Are You Putting in the Formula?

We source Angelica sinensis root as part of the finished-supplement project. Dong Quai extract and Dong Quai root extract describe material types inside that project — not a complete purchase order.

Until species, plant part, extract type, marker, and assay method are named, a lower $/kg price is usually a different material, not a saving.

Material typeWhat you are buyingWhen it fits the SKU
Root powderMilled dried A. sinensis root; identity without a guaranteed marker milligramF02 and some powder blends
Ratio extract (for example 4:1, 10:1, or 20:1)Concentrated root described as an input-to-output ratioCost-sensitive F01 capsules that need extract identity
Ligustilide-specified extractReleased against named Z-ligustilide by HPLC. 1% or 2% HPLC are typical commercial grades — not a pharmacopoeial mandate. Final specification is project-dependentBriefs that will state phthalide content
Ferulic-acid-specified extractReleased against named ferulic acid by HPLC. 0.1%–1% HPLC is the usual quoted band; 0.3% HPLC is commonly specifiedBriefs that want the phenolic-acid marker used on some A. sinensis quality files
Polysaccharide-specified (aqueous) extractWater-extracted grade released against a polysaccharide result by UV (or the named method). 10%, 20%, or 30% UV are typical catalog grades — not interchangeable with HPLC ligustilideBriefs that specify an aqueous polysaccharide input
CustomOrganic-certified raw material, project-specific DER, solvent, or dual-marker specificationNamed market-specific requirements

A 10:1 ratio does not mean 10× ligustilide or ferulic acid. Ratio describes process concentration; marker specification describes an assayed result. Extraction solvent should be declared when the marker profile matters, because different systems produce different material profiles.

Lock Angelica sinensis. European angelica (A. archangelica) and other Angelica species (A. dahurica, A. gigas, A. acutiloba among them) have different chemistry and different label files — they should not be purchased as Dong Quai. High-purity ligustilide isolates, essential oils, and dry powder extracts are also separate commercial materials.

Standardized botanical pathways: Standard Extracts.

Angelica sinensis Extract Specifications Buyers Should Lock

This is the file that makes supplier quotes comparable. Once the material type is chosen, lock the fields that control identity, serving math, process behavior, and the label.

Spec field

Why it matters for your SKUWhat to lock
Botanical identityOther Angelica species are not Dong QuaiAngelica sinensis (Oliv.) Diels
Plant partLeaf, stem, or seed is a different commercial herbDried root
Material typePowder, ratio, ligustilide, ferulic acid, and polysaccharide grades are quoted separatelyNamed type
Extract ratio / DERRatio is not potencyDefined if used (for example 4:1, 10:1, 20:1)
Extraction solventChanges the residual-solvent file and, when the marker profile matters, the fraction you are buyingDeclared (hydroalcohol vs water vs project-specific)
Marker compoundsLigustilide, ferulic acid, and polysaccharide are different analytesNamed analyte; minimum or as-specified
Assay methodA number without a method is not comparableHPLC for ligustilide and/or ferulic acid; polysaccharide method named when used
MoistureCaking, flow, microbial riskSpecification-based
Particle sizeFill-weight variation, capping, poor flowMatched to the capsule filler or press
Carrier / excipientsFill weight, labeling, residual solventsDeclared (none, maltodextrin, or project-specific)
Heavy metals / pesticides / microbiology / residual solventsMarket limits differTested against the destination requirement

Appearance and characteristic root odor belong on the specification as control fields. They also explain why flavored powders and gummies need their own sensory plan.

Serving math

Raw-material weight × assay = marker amount per serving

Illustration only, not a dosage recommendation: 500 mg extract × 1% ligustilide = 5 mg ligustilide. A 500 mg Angelica sinensis extract line on Supplement Facts is not 500 mg ligustilide.

Final serving is confirmed from the selected grade, companion fill, capsule or tablet size, and target market. If the brief only says “Dong Quai 10:1” or “1% extract,” ask: ligustilide, ferulic acid, polysaccharide, or identity only? HPLC or another method? Carrier present?

Send the specification you intend to buy if you need a sample COA for comparison.

Dong Quai Supplement Manufacturing, Stability & Packaging

Consistency is built in process — incoming assay, fill, pack, and dating — rather than copied from a drum COA onto the bottle. F03–F06 and F07 companions are workable in the blender; each still keeps its own incoming specification.

01 — Marker stability

Ligustilide may require tighter process and storage controls than a ferulic-acid-led specification. When the specification depends on ligustilide, handling, headspace, and pack are evaluated during development. An aqueous polysaccharide grade is run against its own assay file.

02 — Odor and sensory control

Characteristic root odor is expected. Capsules isolate it; powders, gummies, and flavored formats need a sensory plan before artwork is locked.

03 — Flow and fill consistency

Low bulk density on root powder and some extracts shows up as fill-weight variation. Particle size, flow aids, and equipment set-up are confirmed at sample — especially for F02 and mineral stacks (F05 and custom nutrient combinations).

04 — Packaging and shelf life

HDPE / PET bottles with induction seals are a common capsule/tablet start. Blisters, pouches, sachets, cartons, and export cases as scoped; desiccant when moisture leads. Pack type is part of dating control.

Final shelf life is confirmed from the formulation, packaging system, storage conditions, and stability data. Incoming extract stability is not finished-SKU dating.

Humidity, barrier, and dating: Moisture Control & Stability Engineering.

Dong Quai OEM Manufacturer Quality Control, COA & Batch Release

The commercial batch is released against the same approved specification used for the sample. The chain is specification → sampling → testing → release. Ask what is tested at each stage, and against which method.

StageWhat is checked
Incoming root / extractIdentity (A. sinensis dried root), appearance, named assay, moisture, microbiology, heavy metals, pesticides, residual solvents as scoped
In-processBlend uniformity, capsule fill or tablet weight, hardness / friability where applicable, process moisture
Finished SKUAgreed specification, microbiology, physical parameters, packaging inspection, batch documentation

A usable Certificate of Analysis should contain four blocks:

  1. Identity: Botanical verification (macroscopic / microscopic and/or HPTLC as scoped)
  2. Potency: Named ligustilide and/or ferulic acid by HPLC; polysaccharide by the agreed method where specified
  3. Safety: Heavy metals, microbiology, pesticides, residual solvents as scoped
  4. Physical: Appearance, moisture, particle size, bulk density as specified

Sample and COA should match the commercial spec you intend to buy.

Lab: in-house release; SGS or Eurofins when the RFQ requires a third-party pack. Limits follow the approved spec and destination market. Methods: Quality Control.

Dong Quai Supplement OEM Manufacturer Process: Brief to Shipment

01 — Send your requirements
Target market, F01–F06 / F07 or BOM, dosage form, quantity, packaging, target cost.

02 — Target market and specification review
Species, claim direction, population restrictions, Angelica sinensis grade, companion specs.

03 — Formula development
Fill weight, compatibility, format feasibility.

04 — Sample
Prototype against the locked specification.

05 — Pilot
Blend uniformity, fill or compression, in-process checks.

06 — Stability / QC as scoped
Dating evidence where the brief requires it.

07 — Production and packaging
Batch manufacture against the approved sample.

08 — Documentation and shipment
COA, batch records, export pack.

MOQ and lead time by format

MOQ and lead time depend on dosage form, formula complexity, packaging, testing, material availability, and production scheduling. A bulk extract kilogram and a finished capsule SKU are quoted separately.

Project stageTypical timeline
Formula discussionProject dependent
Sample development7–15 days*
Pilot production15–25 days*
Mass production30–45 days*
ScopeTypical startWhat usually drives the minimum
Bulk root powder / extract on the projectQuoted by kgGrade, method, drum pack
Capsules~3,000–5,000 unitsCapsule size, fill, pack
Tablets~5,000–10,000 unitsCompression feasibility, pack
Powder / stick — retailOften from ~10,000 unitsFilm, fill, moisture
Gummies / liquidsProject-scopedHeat, taste, assay

Actual MOQ and lead time depend on formula, pack, testing, and schedule.

HDPE / PET bottles | blisters | pouches | sachets | cartons | export master cases | desiccant and tamper-evident finishes as scoped.

Format, pack, and testing drive the project-specific MOQ and lead-time estimate.

Seven Fields for a Usable RFQ

The specification section above is how you choose the material. These seven fields are what we need to return an initial technical review.

FieldWhat to include
1. Target productFinished supplement or bulk-on-project
2. Material typeRoot powder / ratio / ligustilide / ferulic acid / polysaccharide / “recommend”
3. Marker and methodNamed % + HPLC or named polysaccharide method — or “recommend”; attach a CoA if matching
4. FormulaF01–F06, F07, or BOM
5. FormatCapsules / tablets / powder / softgel (if oil-based) / other after feasibility
6. QuantityFirst PO + annual forecast
7. Target marketCountry + classification + channel

A complete brief is usually enough for an initial technical review within two business days.

Integrated Dong Quai Manufacturing

Ingredient sourcing, formulation, manufacturing, QC, packaging, and export sit on one program — so you do not need a separate extract trader, formulator, filler, and packer for this project.

Site-level capacity (confirmed): 5 integrated bases · 81,000+ m² · 2 R&D centers · 12 automated production lines · 260+ professionals · since 2007 · 500+ brand projects · 60+ export markets.

Certifications: cGMP · ISO 9001 · ISO 22000 · HACCP · FSSC 22000 · Halal · Kosher.

Gummies and liquids exist as lines. Dong Quai in those formats remains project-scoped.

Site-level figures: Manufacturing Capacity.

Start Your Dong Quai Supplement Project

You do not need a finished formula to start. A selling market, a format, and a grade direction are enough for an initial technical review. If you already have a CoA or a BOM, send that — we will tell you whether the quotes in front of you are actually comparable.

Name the country the SKU will sell into, whether it is F01–F06, F07, or a custom BOM, and whether the label will state ligustilide, ferulic acid, polysaccharide, or Angelica sinensis root identity only.

Have a BOM? Send Your BOM

Still choosing a grade? Get a Dong Quai Spec Recommendation

Comparing suppliers? Send Your COA for Comparison

Related Resources

Get an Instant Quote Now
Quick Quote
Scroll to Top